British American Tobacco maintained its 2024 guidance of low-single-digit organic revenue growth as it reported performance for the first half of the year in line with its expectations.
![](https://immunet.online/wp-content/uploads/2024/06/medium-i0Ok6y.jpeg)
British American Tobacco maintained its 2024 guidance of low-single-digit organic revenue growth as it reported performance for the first half of the year in line with its expectations.